Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,936 shares at $116.74 ($459K) on 2025-02-13, disclosed to the SEC on 2025-02-14.
Scheduled sale ($459k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.74 | 604 | $71K | 15.4% |
| 2 | $116.74 | 604 | $71K | 15.4% |
| 3 | $116.90 | 1,114 | $130K | 28.4% |
| 4 | $116.90 | 1,114 | $130K | 28.4% |
| 5 | $115.04 | 500 | $58K | 12.5% |
| Total | $116.61 avg | 3,936 |
| $459K |
| 100% |
| Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |
| NBIX | SELL | 2024-02-02 | $410K | — | Filing → |